Prophase Labs Share Price Today
(NASDAQ: PRPH)

Name: Prophase Labs Share Price Today (NASDAQ: PRPH) - Prophase Labs Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Prophase Labs share price is $0.42 & ₹36.53 as on 6 Mar 2025, 2.30 'hrs' IST

$0.42

▲

0.03

(8.27%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Prophase Labs share price in Dollar and Rupees. Guide to invest in Prophase Labs stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Prophase Labs, along with analyst recommendations, forecasts, and comprehensive financials.

Prophase Labs share price movements

Today's Low: $0.37
Today's High: $0.43
$0.42
11.88%
Downside
Day's Volatility :13.35%
Upside
1.66%
52 Weeks Low: $0.22
52 Weeks High: $7.48
$0.42
48.12%
Downside
52 Weeks Volatility :97.09%
Upside
94.39%

Prophase Labs (PRPH) Returns

Period	Prophase Labs Inc	Index (Russel 2000)
3 Months	-45.38%	0.0%
6 Months	-84.76%	0.0%
1 Year	-91.6%	0.0%
3 Years	-93.94%	-11.6%

Prophase Labs (PRPH) Key Statistics

in dollars & INR

Previous Close	$0.3856
Open	$0.385
Today's High	$0.4271
Today's Low	$0.3701
Market Capitalization	$11.7M
Today's Volume	$122.3K
52 Week High	$7.48
52 Week Low	$0.2179
Revenue TTM	$12.8M
EBITDA	$-27.9M
Earnings Per Share (EPS)	$-1.4
Profit Margin	-217.64%
Quarterly Earnings Growth YOY	-0.95%
Return On Equity TTM	-58.71%

How to invest in Prophase Labs Stock (PRPH) from India?

It is very easy for Indian residents to invest directly in Prophase Labs from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Prophase Labs stock in both Indian Rupees (INR) and US Dollars (USD). Search for Prophase Labs or PRPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Prophase Labs or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Prophase Labs shares which would translate to 2.071 fractional shares of Prophase Labs as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Prophase Labs, in just a few clicks!

Returns in Prophase Labs (PRPH) for Indian investors in Rupees

The Prophase Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Prophase Labs investment value today

Current value as on today

₹14,113

Returns

₹85,887

(-85.89%)

Returns from Prophase Labs Stock

₹90,850 (-90.85%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Prophase Labs (PRPH)

895.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Prophase Labs Shares from India has grown by 895.0% over the past 30 days, indicating increased transactional activity.

1125%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Prophase Labs Stock from India on INDmoney has increased by 1125% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Prophase Labs

Vanguard Group Inc
2.17%
Renaissance Technologies Corp
0.95%
HighTower Advisors, LLC
0.78%
Sheets Smith Wealth Management
0.69%
Geode Capital Management, LLC
0.67%
Perritt Capital Management Inc.
0.63%

Analyst Recommendation on Prophase Labs

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Prophase Labs(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Prophase Labs Stock (PRPH)

What analysts predicted

Upside of 3185.71%

Target:

$13.80

Current:

$0.42

Insights on Prophase Labs Stock (Ticker Symbol: PRPH)

Price Movement
In the last 1 month, PRPH stock has moved up by 50.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.47M → 3.14M (in $), with an average increase of 21.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -6.15M → -6.58M (in $), with an average decrease of 7.1% per quarter
PRPH vs TMO (1 yr)
In the last 1 year, Prophase Labs Inc has experienced a drawdown of -91.8%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 80.2%
PRPH vs TMO (3 yr)
In the last 3 years, Prophase Labs Inc has experienced a drawdown of -94.1%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 88.5%
Price to Sales
ForPRPH every $1 of sales, investors are willing to pay $0.6, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.6 for every $1 of sales.

PRPH Prophase Labs Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$13.1M	↑ 33.03%
Net Income	$-1.7M	↓ 104.16%
Net Profit Margin	-13.26%	↓ 437.21%

	FY19	Y/Y Change
Revenue	$9.9M	↓ 24.76%
Net Income	$-3.0M	↑ 73.16%
Net Profit Margin	-30.51%	↓ 17.25%

	FY20	Y/Y Change
Revenue	$14.5M	↑ 46.96%
Net Income	$-2.4M	↓ 19.68%
Net Profit Margin	-16.67%	↑ 13.84%

	FY21	Y/Y Change
Revenue	$79.0M	↑ 444.59%
Net Income	$6.3M	↓ 359.21%
Net Profit Margin	7.94%	↑ 24.61%

	FY22	Y/Y Change
Revenue	$122.6M	↑ 55.17%
Net Income	$18.5M	↑ 194.32%
Net Profit Margin	15.05%	↑ 7.11%

	FY23	Y/Y Change
Revenue	$44.4M	↓ 63.81%
Net Income	$-16.8M	↓ 190.9%
Net Profit Margin	-37.81%	↓ 52.86%

	Q2 FY23	Q/Q Change
Revenue	$13.2M	↓ 31.53%
Net Income	$-3.4M	↓ 725.45%
Net Profit Margin	-26.03%	↓ 28.88%

	Q3 FY23	Q/Q Change
Revenue	$8.4M	↓ 36.71%
Net Income	$-5.1M	↑ 49.45%
Net Profit Margin	-61.46%	↓ 35.43%

	Q4 FY23	Q/Q Change
Revenue	$3.5M	↓ 58.17%
Net Income	$-8.8M	↑ 70.22%
Net Profit Margin	-250.1%	↓ 188.64%

	Q1 FY24	Q/Q Change
Revenue	$3.6M	↑ 3.86%
Net Income	$-6.3M	↓ 28.41%
Net Profit Margin	-172.4%	↑ 77.7%

	Q2 FY24	Q/Q Change
Revenue	$2.5M	↓ 31.92%
Net Income	$-6.2M	↓ 1.79%
Net Profit Margin	-248.71%	↓ 76.31%

	Q3 FY24	Q/Q Change
Revenue	$3.1M	↑ 27.16%
Net Income	$-6.6M	↑ 7.05%
Net Profit Margin	-209.38%	↑ 39.33%

	FY18	Y/Y Change
Profit	$4.8M	↑ 145.43%

	FY19	Y/Y Change
Profit	$2.6M	↓ 45.3%

	FY20	Y/Y Change
Profit	$4.6M	↑ 76.14%

	FY21	Y/Y Change
Profit	$32.8M	↑ 612.42%

	FY22	Y/Y Change
Profit	$70.7M	↑ 115.32%

	FY23	Y/Y Change
Profit	$16.2M	↓ 77.02%

	Q2 FY23	Q/Q Change
Profit	$6.4M	↓ 38.71%

	Q3 FY23	Q/Q Change
Profit	$2.3M	↓ 63.91%

	Q4 FY23	Q/Q Change
Profit	$-3.1M	↓ 231.33%

	Q1 FY24	Q/Q Change
Profit	$-433.0K	↓ 85.83%

	Q2 FY24	Q/Q Change
Profit	$-476.0K	↑ 9.93%

	Q3 FY24	Q/Q Change
Profit	$-165.0K	↓ 65.34%

	FY18	Y/Y Change
Operating Cash Flow	$-2.1M	↓ 25.33%
Investing Cash Flow	$11.9M	↓ 45.52%
Financing Cash Flow	$-11.4M	↓ 29.88%

	FY19	Y/Y Change
Operating Cash Flow	$-841.0K	↓ 60.31%
Investing Cash Flow	$5.5M	↓ 53.27%
Financing Cash Flow	$-5.8M	↓ 48.76%

	FY20	Y/Y Change
Operating Cash Flow	$-2.6M	↑ 208.2%
Investing Cash Flow	$-1.0M	↓ 118.33%
Financing Cash Flow	$10.0M	↓ 271.59%

	FY21	Y/Y Change
Operating Cash Flow	$-13.6M	↑ 425.42%
Investing Cash Flow	$-19.7M	↑ 1835.63%
Financing Cash Flow	$35.1M	↑ 251.62%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-7.0M	↓ 1561.55%
Investing Cash Flow	$1.2M	↓ 173.55%
Financing Cash Flow	$-47.0K	↓ 102.8%

Prophase Labs Technicals Summary

Sell

Neutral

Buy

Prophase Labs is currently in a neutral trading position according to technical analysis indicators.

Prophase Labs (PRPH) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Prophase Labs Inc	44.42%	-84.76%	-91.6%	-93.94%	-80.82%
Agilent Technologies Inc.	-16.31%	-11.06%	-15.84%	-5.59%	73.94%
Idexx Laboratories, Inc.	-5.04%	-5.88%	-20.78%	-14.63%	81.86%
Thermo Fisher Scientific, Inc.	-11.02%	-14.88%	-12.67%	-3.4%	74.9%
Danaher Corp.	-4.23%	-22.21%	-18.58%	-21.71%	45.43%
Iqvia Holdings Inc.	-8.23%	-26.02%	-27.43%	-15.27%	48.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Prophase Labs Inc	NA	NA	0.0	-1.27	-0.59	-0.24	NA	2.0
Agilent Technologies Inc.	28.22	28.22	2.06	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	40.97	40.97	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.62	31.62	2.05	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.81	38.81	2.07	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.51	24.51	0.99	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Prophase Labs Inc	Buy	$11.7M	-80.82%	NA	-217.64%
Agilent Technologies Inc.	Buy	$35.1B	73.94%	28.22	19.27%
Idexx Laboratories, Inc.	Buy	$35.6B	81.86%	40.97	22.78%
Thermo Fisher Scientific, Inc.	Buy	$197.5B	74.9%	31.62	14.77%
Danaher Corp.	Buy	$147.0B	45.43%	38.81	16.33%
Iqvia Holdings Inc.	Buy	$32.4B	48.04%	24.51	8.91%

About Prophase Labs

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Organization	Prophase Labs
Employees	113
CEO	Mr. Ted William Karkus
Industry	Consumer Non-Durables

Management People of Prophase Labs

Name	Title
Mr. Ted William Karkus	Chairman & CEO
Mr. Stu Hollenshead	Chief Operating Officer
Mr. Sergio Miralles	Executive VP & Chief Information Officer
Mr. Kamal Obbad	Senior VP and Director of Sales & Marketing - Nebula Genomics
Mr. Jason Karkus	President of Nebula Genomics
Mr. Lance Bisesar	Corporate Controller

Important FAQs about investing in PRPH Stock from India :

What is Prophase Labs share price today?

Prophase Labs share price today stands at $0.42, Open: $0.39 ; Previous Close: $0.39 ; High: $0.43 ; Low: $0.37 ; 52 Week High: $7.48 ; 52 Week Low: $0.22.

The stock opens at $0.39, after a previous close of $0.39. The stock reached a daily high of $0.43 and a low of $0.37, with a 52-week high of $7.48 and a 52-week low of $0.22.

Can Indians buy Prophase Labs shares?

Yes, Indians can invest in the Prophase Labs (PRPH) from India.

With INDmoney, you can buy Prophase Labs at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Prophase Labs at zero transaction cost.

How can I buy Prophase Labs shares from India?

It is very easy to buy Prophase Labs from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Prophase Labs (PRPH) be purchased?

Yes, you can buy fractional shares of Prophase Labs with INDmoney app.

What are the documents required to start investing in Prophase Labs stocks?

To start investing in Prophase Labs, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.